Table 1.
The baseline characteristics of the patients (n = 147).
| Variables | Number (%) or Median (Range) |
|---|---|
| Age (years) | 58 (39–81) |
| FIGO stage | |
| III | 72 (49.0) |
| IV | 75 (51.0) |
| ASA score before NAC | |
| 1 | 8 (5.4) |
| 2 | 80 (54.4) |
| 3 | 58 (39.5) |
| Not applicable | 1 (0.7) |
| Germline BRCA status | |
| Wild | 97 (66.0) |
| BRCA1/2 mutation | 36 (24.5) |
| Not applicable | 14 (9.5) |
| Serum CA-125 level (U/mL) | 1509.0 (94.2–21,994.7) |
| Cycles of NAC | 3 (3–4) |
| Chemotherapy response score | |
| 1 | 4 (2.7) |
| 2 | 98 (66.7) |
| 3 | 45 (30.6) |
| Residual disease after IDS | |
| No gross tumor | 73 (49.7) |
| ≤0.5 cm | 53 (36.0) |
| >0.5 cm and ≤1.0 cm | 21 (14.3) |